3-Amino-2-chlorobenzotrifluoride | CAS:62476-58-8

We serve 3-Amino-2-chlorobenzotrifluoride CAS:62476-58-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Amino-2-chlorobenzotrifluoride

Chemical Name:3-Amino-2-chlorobenzotrifluoride
CAS.NO:62476-58-8
Synonyms:3-Amino-2-chlorobenzotrifluoride
2-Chloro-3-(trifluoromethyl)aniline
2-Chloro-3-(trifluoromethyl)benzenamine
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 217.5±40.0 °C at 760 mmHg
Melting Point 25-28℃
Molecular Formula C7H5ClF3N
Molecular Weight 195.570
Flash Point 85.3±27.3 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.500
 
Specification:
Appearance:Light yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-Amino-2-chlorobenzotrifluoride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-3-(trifluoromethyl)benzenamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Chloro-3-(trifluoromethyl)benzenamine Use and application,3-Amino-2-chlorobenzotrifluoride technical grade,usp/ep/jp grade.


Related News: API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine.2-Bromo-4-fluorotoluene manufacturer Here’s what we can tell you so far:2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate supplier We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.N-butyl-N-[(dibutylamino)disulfanyl]butan-1-amine vendor We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms.